2020
Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer
Kunst N, Wang SY, Hood A, Mougalian SS, DiGiovanna MP, Adelson K, Pusztai L. Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer. JAMA Network Open 2020, 3: e2027074. PMID: 33226431, PMCID: PMC7684449, DOI: 10.1001/jamanetworkopen.2020.27074.Peer-Reviewed Original ResearchMeSH KeywordsAdo-Trastuzumab EmtansineAdultAgedAnthracyclinesAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalAntineoplastic Agents, PhytogenicBreast NeoplasmsCase-Control StudiesCost-Benefit AnalysisCross-Linking ReagentsDrug Therapy, CombinationFemaleHumansImmunosuppressive AgentsMiddle AgedNeoadjuvant TherapyPaclitaxelQuality-Adjusted Life YearsReceptor, ErbB-2TrastuzumabTubulin ModulatorsUnited StatesConceptsErbB2-positive breast cancerAdjuvant treatment strategiesAdjuvant T-DM1Pathologic complete responseT-DM1Treatment strategiesBreast cancerKATHERINE trialResidual diseaseNeoadjuvant regimenHigher health benefitsHealth care payer perspectiveAdjuvant trastuzumab emtansineAnthracycline/cyclophosphamideDifferent adjuvant therapiesFlatiron Health databaseIncremental cost-effectiveness ratioNeoadjuvant treatment optionsHealth benefitsPositive breast cancerCare payer perspectiveCost-effectiveness ratioBase-case analysisDecision analytic modelH. Patients
2005
Treatment of hot flushes in breast and prostate cancer
Adelson KB, Loprinzi CL, Hershman DL. Treatment of hot flushes in breast and prostate cancer. Expert Opinion On Pharmacotherapy 2005, 6: 1095-1106. PMID: 15957964, DOI: 10.1517/14656566.6.7.1095.Peer-Reviewed Original ResearchMeSH KeywordsAminesAntineoplastic Agents, HormonalBreast NeoplasmsCimicifugaContraindicationsCyclohexanecarboxylic AcidsDrug Therapy, CombinationElectroacupunctureExcitatory Amino Acid AntagonistsFemaleGabapentinGamma-Aminobutyric AcidHormone Replacement TherapyHot FlashesHumansMaleNeoplasms, Hormone-DependentOrchiectomyParoxetinePhytotherapyPlant PreparationsProstatic NeoplasmsRandomized Controlled Trials as TopicSelective Serotonin Reuptake InhibitorsConceptsHormone replacement therapyHot flushesBreast cancerReplacement therapyProstate cancerSelective serotonin reuptake inhibitorsChemotherapy-induced menopauseMenopausal age womenMainstay of treatmentThrombo-embolic eventsSerotonin reuptake inhibitorsHealthy menopausal womenCommon health problemHot flush symptomsQuality of lifeMedical castrationHormonal therapyOvarian suppressionAndrogen ablationPerimenopausal periodNonhormonal agentsReuptake inhibitorsSignificant morbidityCancer survivorsMenopausal women